1. COVID-19 vaccination and lethality reduction: a prospective observational study in Venezuela during the last two waves.
- Author
-
Forero-Peña, David A., Leyva, Jéssica L., Valenzuela, María V., Omaña-Ávila, Óscar D., Regalado-Gutiérrez, Oriana A., Mendoza-Millán, Daniela L., Sánchez-Ytriago, Elisanny A., Lahoud-El Hachem, Andrea C., Farro, Katherine R., Maita, Ana K., González, Romina del C., Rodriguez-Saavedra, Carlis M., Hernández-Medina, Fernando, Camejo-Ávila, Natasha A., Freitas-de Nobrega, Diana C., Celis, Rodrigo T., Forero-Peña, José L., Martínez, Alfonso, Grillet, María E., and Landaeta, María E.
- Subjects
- *
THROMBOSIS prevention , *PUBLIC hospitals , *OXYGEN saturation , *ANTIBIOTICS , *ADRENOCORTICAL hormones , *PEARSON correlation (Statistics) , *PHYSICAL diagnosis , *LOW-molecular-weight heparin , *ACADEMIC medical centers , *T-test (Statistics) , *DATA analysis , *VACCINE effectiveness , *SCIENTIFIC observation , *INTERVIEWING , *QUESTIONNAIRES , *FISHER exact test , *LOGISTIC regression analysis , *COVID-19 vaccines , *HOSPITAL mortality , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *REVERSE transcriptase polymerase chain reaction , *SEVERITY of illness index , *MANN Whitney U Test , *CHI-squared test , *SYMPTOMS , *FIBRIN fibrinogen degradation products , *LONGITUDINAL method , *ODDS ratio , *ENOXAPARIN , *ANTIVIRAL agents , *KAPLAN-Meier estimator , *LOG-rank test , *RESEARCH , *MEDICAL records , *ACQUISITION of data , *ARTIFICIAL respiration , *STATISTICS , *COMPARATIVE studies , *CONFIDENCE intervals , *METHYLPREDNISOLONE , *DATA analysis software , *COVID-19 pandemic , *COVID-19 , *VACCINATION status , *ANTIPARASITIC agents , *IMMUNOMODULATORS , *NONPARAMETRIC statistics , *COMORBIDITY , *EPIDEMIOLOGICAL research , *EVALUATION - Abstract
Background: In Venezuela, the predominant vaccines administered are BBIBP-CorV and Gam-COVID-Vac. Despite robust evidence from randomized clinical trials validating the effectiveness of COVID-19 vaccines in mitigating hospitalization and mortality, there is still a lack of post-authorization safety studies conducted within this demographic population. Methods: A prospective observational study from October 5, 2021 to March 31, 2022 encompassed COVID-19 vaccinated and unvaccinated patients from four sentinel hospitals in Venezuela. Patient lethality was predicted using Charlson Comorbidity index. Clinical outcomes were assessed through WHO's COVID-19 Clinical Progression Scale. Results: Out of the 175 patients assessed, 85 (48.6%) were vaccinated. The median Charlson Comorbidity index was 3 points, with no statistically significant differences observed between the groups (p = 0.2). A total of 50 (28.6%) patients died during the study period, with higher proportion of deaths in unvaccinated patients (35.6% vs. 21.2%, p = 0.035). Advanced age (OR = 1.043, 95% CI = 1.015–1.071, p = 0.002) was associated with increased death risk, whereas vaccination against COVID-19 (OR = 0.428, 95% CI = 0.185–0.99, p = 0.047), high oxygen saturation (OR = 0.964, 95% CI = 0.934–0.995, p = 0.024), and enoxaparin administration (OR = 0.292, 95% CI = 0.093–0.917, p = 0.035) were associated with decreased death risk. Conclusion: During the third and fourth waves of the pandemic, COVID-19 vaccination was associated with a 57% reduction in lethality among patients in four public hospitals in Venezuela. Key summary points: Less than half (48.6%) of the patients were vaccinated against SARS-CoV-2. At least one out of four patients died during the study period, mainly in the unvaccinated group. Advanced age was associated with a higher risk of death. Vaccination against COVID-19, high oxygen, and enoxaparin administration were factors associated with a lower risk of death. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF